2014 Hemostasis Gordon Research Conference and Gordon Research Seminar

2014止血戈登研究会议暨戈登研究研讨会

基本信息

批准号：
8784662
负责人：
Andrew S Weyrich
金额：
$ 1.25万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-07-15 至 2015-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8784662
关键词：
Achievement Animal Model Applied Research Area Basic Science Biochemistry Biology Biotechnology Blood Coagulation Factor Blood Platelets Blood Vessels Blood coagulation Cardiovascular Diseases Clinical Research Coagulation Process Commit Communities Development Diagnosis Discipline Disease Ensure Environment Enzymatic Biochemistry Equilibrium Faculty Female Fostering Future Genetic Goals Health Hemorrhage Hemostatic Agents Hemostatic function Human Human Genetics Individual Infection Inflammation International Link Malignant Neoplasms Medical Medicine Minority Molecular Biology Mus Nature Pharmacologic Substance Physicians Play Postdoctoral Fellow Process Proteins Research Research Personnel Role Running Scientist Series Site Students Talents Thrombosis Training Transgenic Animals Travel Woman Work abstracting base catalyst cost disability experience human disease improved innovation interest man meetings posters programs public health relevance social structural biology success symposium tool

项目摘要

DESCRIPTION (provided by applicant): We request partial support for the Hemostasis Gordon Research Seminar (GRS) and Gordon Research Conference (GRC), which will be held at the GRC site in Waterville Valley, NH, July 26th through August 1st, 2014. The GRC meeting on hemostasis began in 1973 and has been held biennially since then. The 2014 conference represents the 32nd meeting in the series and is considered the premiere meeting for hemostasis-based research. The 2014 Hemostasis GRC meeting will be preceded by a GRS meeting dedicated to trainee development and exposure. The GRS meeting is organized and run by trainees, is highly successful, and enhances the profile of trainees at the GRC. The Hemostasis GRS/GRC brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have agreed to participate in the GRS and GRC is impressive and represents top investigators in the field. These speakers and discussion leaders will enhance the stimulating nature of the environment for all attendees, especially junior investigators and trainees. The 2014 Hemostasis GRS and GRC programs include heightened participation from women, minorities, and young investigators compared to previous conferences. Moreover, the 2014 meeting will include a significant number of attendees who are junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The 2014 Hemostasis GRS program includes a keynote presentation from Dr. Jane Freedman, a very successful female physician-scientist, 12 presentations from trainees, and 40 poster discussions. The 2014 Hemostasis GRC program will have 4 poster gatherings and 8 presentation sessions that include: 1. The Vessel Wall in Thrombosis and Coagulation; 2. Thrombosis and Coagulation During Infection; 3. Platelets and Coagulation Factors in Development and Disease; 4. Crosstalk in the Vascular Milieu; 5. Links Between Thrombosis, Coagulation, and Inflammation; 6. Coagulation and Platelets in Disease; 7. Hot Topic Abstract Talks where 8 trainees present their work; and, 8. Defective Hemostasis. The conference will end on the evening of August 1st with a keynote session entitled "The Impact of Mouse and Human Genetics on Thrombosis and Hemostasis".

描述（由申请人提供）：我们请求对止血戈登研究研讨会 (GRS) 和戈登研究会议 (GRC) 提供部分支持，这些研讨会将于 2014 年 7 月 26 日至 8 月 1 日在新罕布什尔州沃特维尔谷的 GRC 地点举行。GRC 止血会议于1973年举办，此后每两年举办一次。 2014 年会议是该系列会议的第 32 次会议，被认为是基于止血的研究的首次会议。 2014 年止血 GRC 会议之前将举行一次专门讨论学员发展和接触的 GRS 会议。 GRS 会议由学员组织和主持，非常成功，提高了学员在 GRC 的形象。止血 GRS/GRC 汇集了对血小板和凝血蛋白的生物学、生物化学和遗传学感兴趣的科学家、参与出血和血栓性疾病治疗的医生以及来自小型和大型制药公司开发止血疾病新疗法的研究人员。该会议具有传奇般的地位，使其成为展示前沿研究和揭示该领域重大进展的论坛。事实上，最近在止血方面取得的一些最引人注目的成就已经在本系列之前的会议上首次亮相，或者是由本次会议促进的协作互动推动的。同意参加 GRS 和 GRC 的受邀演讲者和讨论领袖名单令人印象深刻，他们代表了该领域的顶尖研究人员。这些演讲者和讨论领导者将增强所有与会者，特别是初级与会者的环境的刺激性调查员和实习生。与之前的会议相比，2014 年 Hemostasis GRS 和 GRC 项目的女性、少数族裔和年轻研究人员的参与度有所提高。此外，2014 年的会议将有大量的初级教师、学生、博士后研究员和身体残疾人士参加。 2014年止血 GRS 计划包括一位非常成功的女医师兼科学家 Jane Freedman 博士的主题演讲、12 名学员的演讲以及 40 场海报讨论。 2014年止血GRC项目将有4场海报聚会和8场演讲会议，其中包括： 1. 血栓和凝血中的血管壁； 2.感染期间的血栓形成和凝血； 3. 发育和疾病中的血小板和凝血因子； 4. 血管环境中的串扰； 5. 血栓、凝血和炎症之间的联系； 6. 疾病中的凝血和血小板； 7. 热点话题摘要讲座，8位学员展示自己的作品； 8. 止血不良。会议将于8月1日晚以题为“小鼠和人类遗传学对血栓和止血的影响”的主题演讲结束。